Edgar Pérez‐Barragán

Aging Mexican Women Living with HIV: Responding to Structural Oppression through Agency and Care Practices

Marla Naivi Toiber-Rodríguez, Teresita de Jesús Cabrera-López, Edgar Pérez‐Barragán, Juan Carlos Rodríguez‐Aldama et autres

Introduction. Aging Mexican women living with HIV (AMWLWH) experience intersecting inequities associated with gender, age, socioeconomic status, and in some cases, Indigenous origin, shaping their access to HIV care. Objective: Analyze how AMWLWH respond to these conditions of structural oppression through agency …

cl, mx (code pays fourni par la source)

Penicillin or Ceftriaxone for Neurosyphilis in People With HIV: A Retrospective, Propensity Score–Matched Multicenter Study in Mexico

Rodrigo Benavides, Héctor Orlando Rivera-Villegas, Obed Ocampo-Valdez, Rafael Franco‐Cendejas et autres

Background: Neurosyphilis, ocular syphilis, and otosyphilis occur more frequently among people with HIV-1 and are associated with higher morbidity and treatment failure. Intravenous penicillin G remains the standard therapy but requires hospitalization or prolonged intravenous access, creating barriers that are amplified in …

mx, es, cl (code pays fourni par la source)

Immune Reconstitution Inflammatory Syndrome Related to Antiretroviral Therapy Initiation in People With HIV and Mpox: An Observational Retrospective Study

Juan Carlos Rodríguez‐Aldama, Edgar Pérez‐Barragán, Graciela Hernández‐Silva, Jezer Lezama-Mora et autres

The study aims to compare the outcomes of initiating antiretroviral therapy early vs late in people with HIV and mpox. No worse outcomes were found associated with mpox-related immune reconstitution inflammatory syndrome among those who started antiretroviral treatment early, suggesting initiation as …

mx (code pays fourni par la source)

Clinical characteristics and outcomes of people living with HIV and ocular syphilis during the COVID-19 health emergency

Edgar Pérez‐Barragán, Juan Carlos Rodríguez‐Aldama, Paulina Rodríguez-Badillo, Karyme Guadalupe Villegas-Moreno et autres

BACKGROUND: The global shift in healthcare during the COVID-19 pandemic led to challenges in the care of people living with HIV. METHODS: We conducted a retrospective study that aimed to delineate sociodemographic, clinical characteristics and outcomes, of people living with HIV diagnosed …

mx (code pays fourni par la source)

Clinical-Demographic and Laboratory Profile of the Mother-Child Binomial With Syphilis in a Tertiary-Level Hospital in Mexico.

Samantha Pérez‐Cavazos, Juan Garza, María Mayela Rodríguez Saldívar, Fernando Espinosa Villaseñor et autres

BACKGROUND: Congenital syphilis (CS) remains a major public health problem, and its incidence is increasing worldwide. METHODS: Retrospective, observational, and descriptive study of cases with CS and their mothers at a tertiary-level hospital in Mexico from 2017 to 2022. Medical records of …

mx (code pays fourni par la source)

Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study

José Antonio Mata Marín, Juan Carlos Velasco-Penagos, Stefan Mauss, Mara Soraya Rodríguez-Evaristo et autres

Background People living with HIV (PLWH) starting or switching to an integrase strand transfer inhibitor-based regimen are more likely to experience weight gain than other classes of antiretroviral regimens. The aim of this study was to evaluate the weight gain and metabolic …

de, mx (code pays fourni par la source)

Considerations and Concerns Regarding the Use of Ertapenem in Patients With Hypoalbuminemia: Is It Truly Inappropriate?

Marian Elizabeth Phinder-Puente, Orlando Rubén Pérez‐Nieto, Tania Olga Mondragón-Labelle, Edgar Pérez‐Barragán et autres

To the Editor—We read with great interest the Infectious Diseases Society of America (IDSA) 2023 guidance on the treatment of antimicrobial resistant gram-negative infections. The guideline mentions that in patients with hypoalbuminemia and critical illness, the free fraction of ertapenem increases, leading …

mx (code pays fourni par la source)

Mpox-Related Ophthalmic Disease: A Retrospective Observational Study in a Single Center in Mexico

Paulina Rodríguez-Badillo, Juan Carlos Rodríguez‐Aldama, Lucía del Carmen Gabián-Fortes, Sergio Emilio Sifuentes Rentería et autres

Mpox-related ophthalmic disease has been reported as infrequent. We retrospectively describe the ocular manifestations present in 11 of 100 patients with confirmed mpox; 9 were people with HIV. We suggest that an ophthalmological evaluation should be performed in all patients with ocular …

mx (code pays fourni par la source)

Mpox in people with past infection or a complete vaccination course: a global case series

Aniruddha Hazra, Jason E Zucker, Elizabeth J. Bell, John Michael Flores et autres

BACKGROUND: Since May, 2022, a large global outbreak of human mpox (formerly known as monkeypox) has predominantly affected men who have sex with men. The strain responsible, Clade IIb, has mutated substantially from precursors originating from the 2017-18 outbreak in Nigeria. Immunity …

us, es, fr, it, gb, mx, il, ar, ca (code pays fourni par la source)

HIV viral load and CD4+ count are not associated with experiencing Covid-19 vaccine adverse events: case-control study

Edgar Pérez‐Barragán, José Antonio Mata Marín, Javier Mancilla-Galindo, Ashuin Kammar‐García et autres

mx (code pays fourni par la source)

Risk factors for mortality and clinical presentation of monkeypox

Salma Triana-González, Cristina Román-López, Stefan Mauss, Ana Luz Cano-Díaz et autres

OBJECTIVES: To describe risk factors for mortality and clinical characteristics in patients with mpox infection at a reference hospital in Mexico. DESIGN: A prospective cohort study was conducted from September to December 2022 at Hospital de Infectología La Raza National Medical Center. …

mx, de (code pays fourni par la source)

Weight Gain After 12 Months of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV Patients

Edgar Pérez‐Barragán, Mónica Fernanda Guevara-Maldonado, Javier Mancilla-Galindo, Ashuin Kammar‐García et autres

Recent studies suggest that the introduction of antiretroviral agents such as integrase strand transfer inhibitors (INSTI) may lead to weight gain in people living with HIV (PLHIV). In this retrospective observational study, we report the weight changes observed in virologically suppressed HIV …

mx, gt (code pays fourni par la source)